Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysis

doi:10.5306/wjco.v13.i4.287

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4484)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

208

WORD

106

HTML

1570

Figures (1-3)

328

Tables (1-5)

276

Sum=2488

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

231

Download

747

Sum=978

Publishing Process of This Article

Item

Count

Browse

316

Download

702

Sum=1018

Apr 24, 2022 (publication date) through Jan 13, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Apr 24, 2022; 13(4): 287-302
Published online Apr 24, 2022. doi: 10.5306/wjco.v13.i4.287

Full Size Figure Download Figure

Figure 2 Overall survival according to fluorine-18-fluorodeoxyglucose positron-emission tomography status in anatomical regions of interest. A: Breast; B: Axillary; C: Distant; D: Sternal; E: Any axillary, sternal or distant; F: Any axillary or sternal.

Citation: Perrin J, Farid K, Van Parijs H, Gorobets O, Vinh-Hung V, Nguyen NP, Djassemi N, De Ridder M, Everaert H. Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysis. World J Clin Oncol 2022; 13(4): 287-302
URL: https://www.wjgnet.com/2218-4333/full/v13/i4/287.htm
DOI: https://dx.doi.org/10.5306/wjco.v13.i4.287